Format

Send to

Choose Destination
Zhongguo Yi Liao Qi Xie Za Zhi. 2012 Sep;36(5):365-9.

[Discussion on the key aspects of risk control and problems of quality management systems for allogeneic bone products].

[Article in Chinese]

Author information

1
Center for Certification of Drug, State Food and Drug Administration of China, Beijing, 100061. sltian1@yahoo.com.cn

Abstract

From the view of the potential risks of allogeneic bone products in clinical use. the key aspects of risk control and quality management for these products are discussed, as well as the general problems existing in the quality management system of their production enterprises in China are briefly introduced.

PMID:
23289344
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center